GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Therma Bright Inc (FRA:JNX) » Definitions » EBIT

Therma Bright (FRA:JNX) EBIT : €-1.79 Mil (TTM As of Apr. 2024)


View and export this data going back to 2017. Start your Free Trial

What is Therma Bright EBIT?

Therma Bright's earnings before interest and taxes (EBIT) for the three months ended in Apr. 2024 was €-0.22 Mil. Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Apr. 2024 was €-1.79 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. Therma Bright's annualized ROC % for the quarter that ended in Apr. 2024 was -32.92%. Therma Bright's annualized ROC (Joel Greenblatt) % for the quarter that ended in Apr. 2024 was -2,294.74%.

EBIT is also linked to Joel Greenblatt's definition of earnings yield. Therma Bright's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Apr. 2024 was -11.14%.


Therma Bright EBIT Historical Data

The historical data trend for Therma Bright's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Therma Bright EBIT Chart

Therma Bright Annual Data
Trend Jul14 Jul15 Jul16 Jul17 Jul18 Jul19 Jul20 Jul21 Jul22 Jul23
EBIT
Get a 7-Day Free Trial Premium Member Only Premium Member Only -0.27 -0.39 -5.81 -4.47 -2.57

Therma Bright Quarterly Data
Jul19 Oct19 Jan20 Apr20 Jul20 Oct20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24 Apr24
EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.39 -1.40 -0.10 -0.08 -0.22

Competitive Comparison of Therma Bright's EBIT

For the Medical Devices subindustry, Therma Bright's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Therma Bright's EV-to-EBIT Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Therma Bright's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Therma Bright's EV-to-EBIT falls into.



Therma Bright EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

EBIT for the trailing twelve months (TTM) ended in Apr. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €-1.79 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Therma Bright  (FRA:JNX) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

Therma Bright's annualized ROC % for the quarter that ended in Apr. 2024 is calculated as:

ROC % (Q: Apr. 2024 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: Jan. 2024 ) + Invested Capital (Q: Apr. 2024 ))/ count )
=-0.872 * ( 1 - 0% )/( (2.626 + 2.672)/ 2 )
=-0.872/2.649
=-32.92 %

where

Note: The Operating Income data used here is four times the quarterly (Apr. 2024) data.

2. Joel Greenblatt's definition of Return on Capital:

Therma Bright's annualized ROC (Joel Greenblatt) % for the quarter that ended in Apr. 2024 is calculated as:

ROC (Joel Greenblatt) %(Q: Apr. 2024 )
=EBIT/Average of (Net fixed Assets + Net Working Capital)
=EBIT/Average of (Property, Plant and Equipment+Net Working Capital)
     Q: Jan. 2024  Q: Apr. 2024
=EBIT/( ( (Property, Plant and Equipment + Net Working Capital) + (Property, Plant and Equipment + Net Working Capital) )/ count )
=-0.872/( ( (0.041 + max(-1.302, 0)) + (0.035 + max(-1.587, 0)) )/ 2 )
=-0.872/( ( 0.041 + 0.035 )/ 2 )
=-0.872/0.038
=-2,294.74 %

where Working Capital is:

Working Capital(Q: Jan. 2024 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(0 + 0.118 + 0.035) - (1.455 + 0 + 0)
=-1.302

Working Capital(Q: Apr. 2024 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(0 + 0.117 + 0.034) - (1.737 + 0 + 0.00099999999999989)
=-1.587

When net working capital is negative, 0 is used.

Note: The EBIT data used here is four times the quarterly (Apr. 2024) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

Therma Bright's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %=EBIT (TTM)/Enterprise Value (Q: Apr. 2024 )
=-1.788/16.055
=-11.14 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Therma Bright EBIT Related Terms

Thank you for viewing the detailed overview of Therma Bright's EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.


Therma Bright Business Description

Traded in Other Exchanges
Address
345 Danforth Avenue, Toronto, ON, CAN, M4K 1N7
Therma Bright Inc is a medical diagnostic and device technology company focused on providing consumers and medical professionals with solutions to address important medical and healthcare challenges. The Company's initial proprietary technology delivers non-invasive and pain-free skincare. The company's products include AcuVid, InterceptCS, Benepod, Venowave, TheroZap, Inretio and others.TherOZap and InterceptCS. The InterceptCS system provides controlled topical heat, without the risk of burning the skin, which will naturally prevent cold sore outbreaks. The TherOZap thermal therapy reduces the inflammatory response, relieving the symptoms of pain, itch, and inflammation associated with bites and stings.

Therma Bright Headlines

No Headlines